Market Trends of Patient Monitoring Industry
The Cardiology Segment is Expected to Witness Considerable Market Growth Over the Forecast Period
In cardiology, patient monitoring devices are used to diagnose and monitor various disorders or abnormalities of the heart and the overall cardiovascular system. The major factor driving the growth of the Cardiac Monitoring Market is the rising number of cases and deaths due to cardiovascular diseases and the increasing number of cardiac surgeries. For instance, according to the CDC update in January 2023, around 6.2 million adults in the United States have heart failure yearly. Similarly, according to the journal published by HexaHealth in October 2022, around 200,000 surgeries were performed in the United States and 60,000 in India annually. Post-surgery, continuous Patient Monitoring is essential to track any possibility of complications and the recovery rate, in which cardiac patient monitoring comes into play. Thus, increasing cardiac surgeries are also expected to surge the segment growth.
Furthermore, product launches and favorable initiatives by the market players in the cardiac monitoring space are also likely to fuel the growth of this segment. For instance, in June 2022, GE Healthcare launched its Wireless Patient Monitoring Devices system, Portrait Mobile. The product helps capture respiration rate, oxygen saturation, and pulse rate for general ward and post-surgery patients continuously, allowing clinicians to act early and avert serious adverse events. Similarly, in January 2021, Boston Scientific Corporation acquired Preventice Solutions, Inc., a privately held company offering remote and Wearable Patient Monitors for adults and pediatric patients. The acquisition will establish a strong footprint for Boston Scientific Corporation in the implantable cardiac monitor market. It is an implantable diagnostic device for detecting arrhythmias. Therefore, owing to the above factors, the Cardiac Monitoring Market segment is anticipated to grow considerably over the forecast period.
North America Region Holds a Considerable Market Share Over the Forecast Period
The North American Patient Monitoring Market is expected to witness considerable growth and is estimated to show a similar trend over the forecast period. The increasing geriatric population, rising incidences of chronic diseases, growing demand for wireless and portable systems, and sophisticated reimbursement structures aimed at cutting out-of-pocket expenditure levels are the major factors attributed to its large Market Share. For instance, according to a report published by the Public Health Agency of Canada in December 2021, the crude incidence rate per 100,000 persons aged 65 years and more for ischemic heart disease was 2,306.9 in men and 1,537 for women, and chronic obstructive pulmonary disease was 1,750.6 in men and 1,411.4 in women. In addition, according to the report published by the Canadian Chronic Disease Surveillance System in November 2022, the overall number of adults aged 65 years and older who were to be living with chronic conditions were expected to be about 6.3 million in the coming years. Thus, owing to such instances, considerable market growth is expected over the forecast period.
In North America, the United States is expected to witness significant growth over the forecast period. The product launches by the key players and product approvals in the country are the major drivers for the market. For instance, in July 2021, Abbott introduced Jot Dx, an insertable cardiac monitor. It is designed to reduce data burden and diagnose abnormal heart rhythms. Similarly, in July 2022, Switzerland-based medical technology company Sleepiz received the U.S. FDA clearance for Sleepiz One+, a Contactless Vital Signs Monitoring and heart rate measuring device, and was launched in the United States. Sleepiz One+ is one of the first Respiratory Monitoring Devices that non-contactly monitors and records patient data during sleep. Sleepiz technology enables a new perspective on patient health, as doctors no longer rely on random check-up measurements but instead have access to continuous data. Thus, owing to the launch of innovative products and the rising prevalence of chronic diseases in the North American region, the market is expected to witness a high growth rate over the forecast period.
